Deferred Tax Assets, Valuation Allowance in USD of BioSig Technologies, Inc. from Q4 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioSig Technologies, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2024.
  • BioSig Technologies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2024 was $47M, a 15.2% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)

BioSig Technologies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $47M -$8.44M -15.2% Dec 31, 2024 10-K 2025-04-15
Q4 2023 $55.4M +$7.74M +16.2% Dec 31, 2023 10-K 2025-04-15
Q4 2022 $47.7M +$16.5M +53% Dec 31, 2022 10-K 2024-04-16
Q4 2021 $31.2M +$6.47M +26.2% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $24.7M +$9.2M +59.4% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $15.5M +$8.3M +115% Dec 31, 2019 10-K 2021-03-15
Q4 2018 $7.2M -$1M -12.2% Dec 31, 2018 10-K 2020-03-13
Q4 2017 $8.2M +$2.7M +49.1% Dec 31, 2017 10-K 2019-03-15
Q4 2016 $5.5M +$1.8M +48.6% Dec 31, 2016 10-K 2018-02-27
Q4 2015 $3.7M +$1.4M +60.9% Dec 31, 2015 10-K 2017-04-11
Q4 2014 $2.3M +$900K +64.3% Dec 31, 2014 10-K 2016-03-14
Q4 2013 $1.4M Dec 31, 2013 10-K 2015-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.